Choosing Inhaled Treprostinil: Matching Device to Patient

This microlearning activity provides a concise, practice-focused exploration of inhaled treprostinil delivery options for pulmonary arterial hypertension. While these therapies share the same active medication, differences in delivery systems introduce practical considerations that influence how treatment is initiated, titrated, and sustained.

Through guided questions, real-world patient scenarios, and a structured decision-making framework, learners examine how patient-specific factors—such as lifestyle, dexterity, tolerability, and treatment preferences—shape delivery system selection. Rather than emphasizing a single “correct” choice, this activity supports clinical reasoning and patient-centered decision-making in everyday practice.

Learning Objectives

• Identify key similarities across inhaled treprostinil delivery options.
• Recognize meaningful differences among delivery approaches that may impact patient use.
• Apply a patient-centered framework to support delivery system decisions in clinical practice.

This activity is sponsored by United Therapeutics.